Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,14700Cr 1.22TCr 1.1TCr 1.02TCr 920.08Cr 1.73TCr 1.8TCr 12TCr 4.86TCr 61TCr 4.57TCr 4.47TCr 1,94500Cr P/E 2027 *
31.3x
P/E 2028 * 23.6x
Enterprise Value 1,11700Cr 1.18TCr 1.07TCr 992.78Cr 895.74Cr 1.69TCr 1.75TCr 12TCr 4.73TCr 60TCr 4.44TCr 4.35TCr 1,89400Cr EV / Sales 2027 *
3.18x
EV / Sales 2028 * 2.79x
Free-Float
68.54%
Yield 2027 *
0.54%
Yield 2028 * 0.61%
1 day+0.07%
1 week-1.14%
Current month+4.02%
1 month+14.26%
3 months+20.13%
6 months+8.30%
Current year+4.99%
1 week 14.6
Extreme 14.605
15.03
1 month 13.02
Extreme 13.015
15.08
Current year 11.36
Extreme 11.36
15.67
1 year 11.36
Extreme 11.36
15.67
3 years 11.36
Extreme 11.36
16.89
5 years 9.58
Extreme 9.576
16.89
10 years 5.63
Extreme 5.626
16.89
Manager TitleAgeSince
Chief Executive Officer 59 01/07/2019
Director of Finance/CFO - 01/08/2024
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 13/05/2014
Chairman 65 02/04/2013
Director/Board Member 65 25/10/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-1.14% - - 1.22TCr
+1.26%+6.61%+40.79%+145.27% 1,28600Cr
+0.79%+3.45%+45.84%+92.04% 69TCr
+0.20%+1.28%+26.97%+114.41% 52TCr
-0.44%+3.69%+41.45%+70.04% 39TCr
+0.55%+0.70%+59.02%+45.79% 36TCr
-0.12%+0.74%+28.39%+60.32% 30TCr
+0.37%+0.37%+3.33%+38.57% 29TCr
-0.30%+1.14%+38.29%+70.56% 25TCr
+0.08%+0.71%+34.44%+123.99% 21TCr
Average +0.25%+2.08%+35.39%+84.55% 48TCr
Weighted average by Cap. +0.54%+3.26%+37.70%+99.28%

Financials

2027 *2028 *
Net sales 35TCr 372.56Cr 337.61Cr 312.27Cr 281.75Cr 530.96Cr 549.68Cr 3.75TCr 1.49TCr 19TCr 1.4TCr 1.37TCr 60TCr 39TCr 416.99Cr 377.87Cr 349.51Cr 315.35Cr 594.28Cr 615.22Cr 4.2TCr 1.66TCr 21TCr 1.56TCr 1.53TCr 67TCr
Net income 3.65TCr 39Cr 35Cr 32Cr 29Cr 55Cr 57Cr 389.75Cr 154.54Cr 1.95TCr 145.26Cr 142.18Cr 6.19TCr 4.92TCr 52Cr 47Cr 44Cr 39Cr 74Cr 77Cr 525.47Cr 208.36Cr 2.63TCr 195.84Cr 191.69Cr 8.34TCr
Net Debt -3.03TCr -32Cr -29Cr -27Cr -24Cr -46Cr -47Cr -324.02Cr -128.48Cr -1.62TCr -120.77Cr -118.2Cr -5.15TCr -4.93TCr -52Cr -47Cr -44Cr -40Cr -74Cr -77Cr -525.99Cr -208.57Cr -2.63TCr -196.04Cr -191.88Cr -8.35TCr
Projected Income Statement - Annual - Dr. Reddy's Laboratories Limited
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
27,527
Date Price Change Volume
13/26/13 $14.74 +0.07% 37,13,807
12/26/12 $14.73 -0.74% 16,54,035
11/26/11 $14.84 -0.13% 21,76,818
10/26/10 $14.86 -1.26% 17,99,068
09/26/09 $15.05 +0.94% 25,91,640
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Dr. Reddy's Laboratories Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
37
Last Close Price
1,377.00INR
Average target price
1,358.95INR
Spread / Average Target
-1.31%